Imagine a disease that slowly scars your lungs, making it harder and harder to breathe, and doctors don't know exactly what causes it. That's idiopathic pulmonary fibrosis (IPF). A new report has taken a first look at which U.S. industries and jobs see deaths from this condition. It's a description of patterns, not a study of causes. The report didn't track individual workers over time or compare them to people in other jobs. It simply described where these tragic deaths are occurring. Because this is an observational report, it can't tell us if a specific job actually causes IPF. Many other factors, like genetics or other environmental exposures, could be at play. The findings are a starting point—a map showing where scientists might want to dig deeper to understand if workplace exposures are a piece of the IPF puzzle.
Which jobs are linked to a deadly lung disease? A new report looks at U.S. workers.
Photo by Nisuda Nirmantha / Unsplash
What this means for you:
A report maps IPF deaths by job, pointing to areas for future safety research. More on Idiopathic Pulmonary Fibrosis
Review of genetic risk variants in idiopathic pulmonary fibrosis among non-European individuals shows limited transferability. One Gene Variant Drives Lung Scarring Across All Ancestries
medRxiv · Apr 26, 2026
Polygenic risk scores improve identification of rare variant carriers in idiopathic pulmonary fibrosis patients. Can a genetic test help spot hidden lung disease risks in pulmonary fibrosis patients?
medRxiv · Apr 19, 2026
FDA Approves Nintedanib Capsules (nintedanib esylate) for Idiopathic Pulmonary Fibrosis and Progressive Fibrosing ILDs FDA approves a new drug to treat two types of progressive, scarring lung diseases.
FDA · Apr 7, 2026
FDA Approves Nintedanib Capsules (nintedanib esylate) for Idiopathic Pulmonary Fibrosis and Progressive Fibrosing ILDs FDA approves a new drug to treat two serious, scarring lung diseases in adults.
FDA · Apr 7, 2026